12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Hemispherx, Lipotec sales and marketing update

Lipotec's GP Pharm Latinoamerica exercised an option for an exclusive license to market Hemispherx's Alferon N interferon alfa-n3 in Argentina under...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >